← Leaderboards
Daryl Faulds
Gemmus Pharma, Inc.
$231,231
Attributed
$231,231
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$231,231 · 1
By mechanism
R43$231,231 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Agonist”
- John M Lachin · George Washington University$118,921,924
- David M Nathan · Massachusetts Institute Of Technology$118,921,924
- Alan G. Barbour · University Of California Irvine$40,092,035
- Alexandros Makriyannis · University Of Connecticut Storrs$29,942,402
- Scott T Weiss · University Of California, San Diego$28,624,344
- John Didsbury · T3d Therapeutics, Inc.$25,150,614
Research focus
AgonistAgreementAnimal Disease ModelsAnimalsAntiviral AgentsAreaCd8-Positive T-LymphocytesCellular AssayCessation Of LifeChemokineClinical TrialsCollaborationsCombined Modality TherapyCommunicable DiseasesComplementCostCytokineDesignDrug CostsDrug Delivery SystemsDrug DiscoveryDrug KineticsEffective TherapyAftercare